14.44
price down icon2.96%   -0.44
after-market Dopo l'orario di chiusura: 14.27 -0.17 -1.18%
loading

Contineum Therapeutics Inc Borsa (CTNM) Ultime notizie

pulisher
05:51 AM

What’s the MACD signal for Contineum Therapeutics Inc.2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru

05:51 AM
pulisher
Feb 11, 2026

Why is Contineum Therapeutics Inc. stock going down2025 Earnings Impact & Daily Profit Focused Stock Screening - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Contineum Therapeutics Submits Phase 2 Trial for PIPE-791 - MSN

Feb 10, 2026
pulisher
Feb 05, 2026

Entry Recap: How sensitive is Contineum Therapeutics Inc to inflationQuarterly Earnings Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Franklin Resources Inc. Expands Holdings in Contineum Therapeuti - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Feb 04, 2026
pulisher
Feb 02, 2026

Trend Review: Is SFBS a top pick in the sectorOptions Play & AI Driven Stock Price Forecasts - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 31, 2026

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 31, 2026
pulisher
Jan 29, 2026

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)January 28, 2026 - BioSpace

Jan 29, 2026
pulisher
Jan 28, 2026

Contineum Therapeutics reports inducement grant under Nasdaq Listing Rule - marketscreener.com

Jan 28, 2026
pulisher
Jan 28, 2026

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule - TradingView

Jan 28, 2026
pulisher
Jan 27, 2026

Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions - Yahoo Finance

Jan 27, 2026
pulisher
Jan 26, 2026

Contineum Therapeutics Adopts 2026 Employment Inducement Equity Plan - TipRanks

Jan 26, 2026
pulisher
Jan 22, 2026

Big Money Moves: Will Contineum Therapeutics Inc stock recover after earningsMarket Performance Recap & High Conviction Trade Alerts - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 20, 2026

Aug EndMonth: Is Contineum Therapeutics Inc currently under institutional pressureWeekly Trend Summary & Long-Term Capital Growth Strategies - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 17, 2026

Take Profit: Will Contineum Therapeutics Inc stock recover after earningsJuly 2025 Outlook & Weekly High Return Opportunities - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Contineum Therapeutics Reports Phase 2 Trial Results - MSN

Jan 16, 2026
pulisher
Jan 13, 2026

Aug Swings: Why Contineum Therapeutics Inc. stock attracts high net worth investorsJuly 2025 Gainers & Daily Momentum Trading Reports - moha.gov.vn

Jan 13, 2026
pulisher
Jan 12, 2026

Growth Review: Is Contineum Therapeutics Inc stock overvalued or fairly priced2025 Breakouts & Breakdowns & Weekly Top Gainers Alerts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 10, 2026

Market Recap: How interest rate cuts could boost Contineum Therapeutics Inc stock2025 Trading Volume Trends & Fast Entry High Yield Tips - Bộ Nội Vụ

Jan 10, 2026
pulisher
Jan 10, 2026

Contineum Therapeutics stock drops as company prices upsized $90 million offering - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Why retail investors favor Contineum Therapeutics Inc. stockDip Buying & Safe Entry Point Identification - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

What risks investors should watch in Contineum Therapeutics Inc. stockInflation Watch & Reliable Intraday Trade Alerts - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Contineum Therapeutics (NASDAQ:CTNM) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jan 10, 2026
pulisher
Jan 09, 2026

Contineum Therapeutics (NASDAQ:CTNM) Receives Equal Weight Rating from Morgan Stanley - Defense World

Jan 09, 2026
pulisher
Jan 08, 2026

Contineum downgraded to Equal Weight from Overweight at Morgan Stanley - TipRanks

Jan 08, 2026
pulisher
Jan 08, 2026

How interest rate cuts could boost Contineum Therapeutics Inc. stockJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

What hedge fund activity signals for Contineum Therapeutics Inc. stockTrade Risk Report & AI Enhanced Execution Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How Contineum Therapeutics Inc. stock compares to market leaders2025 Market WrapUp & AI Driven Stock Movement Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Stock Market Recap: How currency fluctuations impact Contineum Therapeutics Inc stock2025 Market Trends & Short-Term High Return Ideas - moha.gov.vn

Jan 08, 2026
pulisher
Jan 08, 2026

Should I hold or sell Contineum Therapeutics Inc. stock in 2025July 2025 Closing Moves & Safe Entry Momentum Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Setup Watch: How interest rate cuts could boost Contineum Therapeutics Inc. stockGold Moves & Weekly Top Performers Watchlists - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Contineum Therapeutics Inc. stock maintain operating marginsQuarterly Portfolio Report & Fast Moving Stock Trade Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

CTNM: Morgan Stanley Downgrades with Lowered Price Target | CTNM Stock News - GuruFocus

Jan 08, 2026
pulisher
Jan 08, 2026

Contineum Therapeutics (NASDAQ:CTNM) Earns "Equal Weight" Rating from Morgan Stanley - MarketBeat

Jan 08, 2026
pulisher
Jan 08, 2026

Morgan Stanley Downgrades Contineum Therapeutics to Equalweight From Overweight, Adjusts Price Target to $14 From $23 - marketscreener.com

Jan 08, 2026
pulisher
Jan 08, 2026

Contineum Therapeutics stock downgraded by Morgan Stanley on IPF drug concerns - Investing.com Nigeria

Jan 08, 2026
pulisher
Jan 07, 2026

What sentiment indicators say about Contineum Therapeutics Inc. stockSector Performance Review & Explosive Capital Gains - Улправда

Jan 07, 2026
pulisher
Jan 07, 2026

Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jan 07, 2026
pulisher
Dec 31, 2025

Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High? - Finviz

Dec 31, 2025
pulisher
Dec 30, 2025

Lorrain, Contineum Therapeutics CSO, sells $51k in stock - Investing.com India

Dec 30, 2025
pulisher
Dec 30, 2025

Lorrain, Contineum Therapeutics CSO, sells $51k in stock By Investing.com - Investing.com Australia

Dec 30, 2025
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):